Elizabeth A. Maher

机构：Center for Neuro-Oncology, Dana-Farber Cancer Institute · ORCID：0000-0002-9693-5155

发表论文 221 篇 · 总被引 17338 次 · h-index 50

代表论文

• Systematic investigation of mitochondrial transfer between cancer cells and T cells at single-cell resolution (2023 · Cancer Cell · 被引 125)
• Epidermal growth factor receptor and Ink4a/Arf: Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis (2024 · Cancer Cell · 被引 31)
• Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial (2025 · The Lancet Oncology · 被引 26)
• QOL-26. A RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDY OF VORASIDENIB VS PLACEBO IN PATIENTS WITH MUTANT IDH1/2 DIFFUSE GLIOMA (INDIGO): ANALYSIS OF HEALTH-RELATED QUALITY OF LIFE, NEUROCOGNITION AND SEIZURES (2023 · Neuro-Oncology · 被引 21)
• LTBK-06. IMPACT OF VORASIDENIB TREATMENT ON MUTANT IDH1 OR IDH2 DIFFUSE GLIOMA TUMOR GROWTH RATE: RESULTS FROM THE RANDOMIZED, DOUBLE-BLIND, PHASE 3 INDIGO STUDY (2023 · Neuro-Oncology · 被引 18)
• CTNI-53. A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH ADULT-TYPE DIFFUSE GLIOMA WITH AN IDH1/2 MUTATION (INDIGO): UPDATED EFFICACY RESULTS (2024 · Neuro-Oncology · 被引 7)